Antimicrobial Agents Practice Questions

Q: What is the drug of choice for gonococcal and non-gonococcal urethritis?

Azithromycin. **Explanation:** The correct answer is **Azithromycin**. **Why Azithromycin is the Correct Choice:** Urethritis is often "mixed," involving both *Neisseria gonorrhoeae* (gonococcal) and *Chlamydia trachomatis* (non-gonococcal). Azithromycin, a macrolide, is highly effective against *Chlamydia*. While cephalosporins (like Ceftriaxone) are typically the first-line treatment for Gonorrhea, Azithromycin is frequently co-administered to cover potential Chlamydial infection and to combat increasing gonococcal resistance. In many syndromic management protocols (like the WHO and NACO guidelines), a single 1g dose of Azithromycin is a cornerstone for treating uncomplicated urethritis. **Analysis of Incorrect Options:** * **Clindamycin (A):** This lincosamide is primarily used for anaerobic infections and Gram-positive cocci (like MRSA). It has no significant activity against *N. gonorrhoeae* or *C. trachomatis*. * **Cefepime (B):** This is a 4th-generation cephalosporin with broad-spectrum activity, including *Pseudomonas*. While it has Gram-negative coverage, it is not the standard of care for urethritis; 3rd-generation Ceftriaxone is the preferred cephalosporin for Gonorrhea. * **Metronidazole (C):** This is an antiprotozoal and anaerobic agent. It is the drug of choice for *Trichomonas vaginalis* or Bacterial Vaginosis, but it does not cover the primary bacterial causes of urethritis. **High-Yield Clinical Pearls for NEET-PG:** * **Syndromic Management (NACO):** For urethral discharge (Grey Kit), the treatment is a single dose of **Azithromycin (1g)** plus **Cefixime (400mg)**. * **Mechanism:** Azithromycin inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit**. * **Chlamydia Treatment:** If Azithromycin is not used, **Doxycycline** (100mg BID for 7 days) is the alternative first-line agent for non-gonococcal urethritis.

Q: Which of the following is the drug of choice for invasive aspergillosis?

Voriconazole. **Explanation:** **Voriconazole** is the current **drug of choice (DOC)** for invasive aspergillosis. This recommendation is based on clinical trials demonstrating that voriconazole provides superior efficacy and better survival rates compared to conventional Amphotericin B, along with a more favorable safety profile. **Mechanism of Action:** Voriconazole is a second-generation triazole that inhibits the enzyme **14-α-demethylase**, thereby blocking the synthesis of ergosterol, a vital component of the fungal cell membrane. **Analysis of Options:** * **Voriconazole (Option A):** Correct. It is the primary treatment for most forms of invasive aspergillosis. * **Posaconazole (Option B):** While highly effective against *Aspergillus*, it is primarily used for **prophylaxis** in immunocompromised patients (e.g., neutropenic patients) or as salvage therapy when first-line agents fail. * **Amphotericin B (Option C):** Previously the gold standard, it is now considered an alternative (specifically the Liposomal formulation) due to significant nephrotoxicity and lower efficacy compared to voriconazole. * **Caspofungin (Option D):** An echinocandin used as salvage therapy or in combination for refractory cases; it is not used as monotherapy for initial treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects of Voriconazole:** Distinctive **visual disturbances** (photopsia/blurring) occur in ~30% of patients. It is also associated with photosensitivity dermatitis and hepatic enzyme elevation. * **Alternative DOC:** **Isavuconazole** is another first-line agent for invasive aspergillosis, often preferred if the patient has renal impairment or if there is a suspicion of co-infection with Mucormycosis. * **DOC for Allergic Bronchopulmonary Aspergillosis (ABPA):** Oral **Itraconazole** (along with corticosteroids).

Q: What is the drug of choice for uncomplicated cystitis?

Fosfomycin. **Explanation:** The drug of choice for **uncomplicated cystitis** (lower urinary tract infection in non-pregnant women) has shifted in recent years due to increasing resistance patterns. **Fosfomycin** (single 3g dose) and **Nitrofurantoin** are now considered first-line agents. **Why Fosfomycin is correct:** Fosfomycin is a bactericidal antibiotic that inhibits cell wall synthesis by inhibiting the enzyme **enolpyruvate transferase (MurA)**. It is highly effective against common uropathogens, including *E. coli* and *E. faecalis*. Its primary advantage is its unique pharmacokinetic profile: a single oral dose achieves high concentrations in the urine that remain therapeutic for up to 48–72 hours, ensuring high patient compliance. **Why other options are incorrect:** * **Amoxicillin:** No longer used empirically for UTIs due to high rates of resistance among *E. coli* strains. It is only used if the organism is known to be susceptible. * **Chloramphenicol:** Primarily used for enteric fever or bacterial meningitis (in specific cases). It is not indicated for UTIs due to its significant toxicity profile (e.g., bone marrow suppression). * **Cotrimoxazole:** Previously a first-line drug, it is now reserved for cases where local resistance rates are known to be low (<20%). Widespread resistance has diminished its utility as a primary choice. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Fosfomycin inhibits the first step of peptidoglycan synthesis (conversion of NAG to NAM). * **Pregnancy:** Both Fosfomycin and Nitrofurantoin are generally considered safe in pregnancy (Category B), though Nitrofurantoin should be avoided at term. * **Nitrofurantoin Note:** It is ineffective in pyelonephritis (upper UTI) because it does not achieve therapeutic concentrations in the renal parenchyma.

Q: Which antibiotic accentuates the neuromuscular blockade produced by pancuronium?

Streptomycin. The correct answer is **Streptomycin**. **1. Why Streptomycin is correct:** Aminoglycosides (like Streptomycin, Gentamicin, and Neomycin) are well-known for their ability to produce neuromuscular blockade [2]. They act by two primary mechanisms: * **Presynaptic:** They inhibit the release of Acetylcholine (ACh) from the motor nerve terminal by competing with Calcium ions at the voltage-gated calcium channels [2]. * **Postsynaptic:** They reduce the sensitivity of the nicotinic ACh receptors at the motor endplate. When administered with non-depolarizing neuromuscular blockers like **Pancuronium**, aminoglycosides act synergistically, significantly prolonging and intensifying the muscle paralysis [1]. This effect can be partially reversed by Calcium gluconate or Neostigmine [1]. **2. Why the other options are incorrect:** * **Erythromycin:** While Macrolides are potent enzyme inhibitors (CYP450), they do not possess intrinsic neuromuscular blocking properties. * **Penicillin G:** Beta-lactams primarily act on cell wall synthesis and do not interfere with the neuromuscular junction. * **Chloramphenicol:** This drug inhibits bacterial protein synthesis (50S subunit) but does not affect calcium channels or ACh release at the motor endplate. **3. High-Yield Clinical Pearls for NEET-PG:** * **Order of Potency for NM Blockade:** Neomycin > Streptomycin > Amikacin > Gentamicin. * **Contraindication:** Aminoglycosides are strictly contraindicated in patients with **Myasthenia Gravis** as they can precipitate a severe myasthenic crisis. * **Other drugs that potentiate NM blockers:** Magnesium salts, Calcium channel blockers, Volatile anesthetics (Isoflurane), and Quinidine. * **Management:** Intravenous **Calcium Gluconate** is the preferred treatment to antagonize aminoglycoside-induced blockade.

Q: Ketoconazole is useful in all of the following except?

Tinea capitis. **Explanation:** The correct answer is **Tinea capitis** because Ketoconazole (a first-generation imidazole) has poor penetration into hair follicles and does not achieve therapeutic concentrations in the hair shaft. **1. Why Tinea capitis is the correct answer:** Tinea capitis involves infection of the hair shaft and follicles [3]. Management requires systemic antifungal agents that accumulate in keratinized tissues. **Griseofulvin** remains the gold standard (DOC), while Terbinafine and Itraconazole are effective alternatives. Ketoconazole is generally avoided for Tinea capitis due to its limited efficacy in hair and its significant side-effect profile, which include severe hepatitis and inhibition of enzymes involved in steroid hormone biosynthesis [1]. **2. Why the other options are incorrect:** * **Tinea cruris (A), Tinea versicolor (B), and Tinea corporis (D):** These are superficial fungal infections of the glabrous (smooth) skin or the stratum corneum [2]. Ketoconazole, especially in topical formulations (creams/shampoos), is highly effective against these dermatophytes and *Malassezia furfur* [1]. Since these infections do not involve deep hair follicle penetration, topical imidazoles are first-line treatments. **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Ketoconazole inhibits the enzyme **14-α demethylase**, preventing the conversion of lanosterol to ergosterol, a vital component of the fungal cell membrane. * **Endocrine Side Effects:** It inhibits Cytochrome P450 enzymes, leading to decreased testosterone and cortisol [1]. This can cause **gynecomastia**, loss of libido, and menstrual irregularities. * **Drug of Choice (DOC):** While Ketoconazole is used for Tinea versicolor, **Griseofulvin** is the DOC for Tinea capitis, and **Terbinafine** is the DOC for Onychomycosis.

Q: Which of the following drugs does NOT inhibit bacterial cell wall synthesis?

Spectinomycin. ### Explanation The bacterial cell wall is a complex structure primarily composed of peptidoglycan. Drugs targeting its synthesis are generally bactericidal. **1. Why Spectinomycin is the Correct Answer:** Spectinomycin is an **aminocyclitol antibiotic** (related to aminoglycosides). Its mechanism of action is the **inhibition of protein synthesis** by binding to the **30S ribosomal subunit**. It does not interfere with peptidoglycan synthesis. Historically, its primary clinical use was as an alternative treatment for *Neisseria gonorrhoeae* in patients allergic to penicillin. **2. Why the Other Options are Incorrect:** * **Vancomycin (Option B):** A glycopeptide antibiotic that inhibits cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of the nascent peptidoglycan pentapeptide, preventing transglycosylation and transpeptidation. * **Aztreonam (Option C):** A **Monobactam** (Beta-lactam) that inhibits cell wall synthesis by binding to **Penicillin-Binding Protein 3 (PBP-3)**, specifically in Gram-negative bacteria. * **Cephalexin (Option D):** A **First-generation Cephalosporin** (Beta-lactam) that inhibits the final transpeptidation step of cell wall synthesis by binding to PBPs. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for Cell Wall Inhibitors:** "**V**ery **B**ad **P**eople **C**an't **F**ight" (**V**ancomycin, **B**eta-lactams, **P**hosphomycin, **C**ycloserine, **B**acitracin). * **Spectinomycin vs. Aminoglycosides:** Unlike aminoglycosides, spectinomycin is **bacteriostatic** and does not cause significant ototoxicity or nephrotoxicity. * **Vancomycin Resistance:** Occurs via a change in the binding site from D-Ala-D-Ala to **D-Ala-D-Lac**.

Q: Which of the following antibiotics acts by inhibiting the 30S ribosomal subunit?

Tetracycline. **Explanation:** Protein synthesis inhibitors are a high-yield topic for NEET-PG. To understand the correct answer, one must distinguish between drugs acting on the 30S and 50S ribosomal subunits. **1. Why Tetracycline is Correct:** Tetracyclines (and Aminoglycosides) specifically target the **30S ribosomal subunit**. Tetracycline acts by binding reversibly to the 30S subunit, preventing the attachment of aminoacyl-tRNA to the 'A' site on the mRNA-ribosome complex. This halts the addition of amino acids to the growing peptide chain, making it **bacteriostatic**. **2. Why the Other Options are Incorrect:** * **Chloramphenicol:** Acts on the **50S subunit** by inhibiting the enzyme peptidyltransferase, preventing peptide bond formation. * **Erythromycin (Macrolide):** Acts on the **50S subunit** by binding to the 23S rRNA, which inhibits the translocation step (movement of tRNA from A to P site). * **Penicillin:** This is a Beta-lactam antibiotic. It does not inhibit protein synthesis; instead, it inhibits **cell wall synthesis** by binding to Penicillin-Binding Proteins (PBPs) and preventing peptidoglycan cross-linking. **Clinical Pearls for NEET-PG:** * **Mnemonic for 30S vs 50S:** "**Buy AT 30, CEL at 50**" * **30S:** **A**minoglycosides (Bactericidal), **T**etracyclines (Bacteriostatic). * **50S:** **C**hloramphenicol, **E**rythromycin (Macrolides), **L**inezolid/Clindamycin. * **Tetracycline Side Effects:** Fanconi syndrome (expired tetracyclines), tooth discoloration, and phototoxicity. * **Aminoglycosides:** The only protein synthesis inhibitors that are **bactericidal** and cause irreversible inhibition of the 30S subunit.

Q: Aminoglycosides affect which part of the cochlea?

Outer hair cells in the basal area. **Explanation:** Aminoglycosides (e.g., Gentamicin, Amikacin, Neomycin) are notorious for their **ototoxicity**, which can manifest as either vestibular or cochlear damage. **Why Option A is correct:** The primary site of damage in aminoglycoside-induced cochleotoxicity is the **Outer Hair Cells (OHCs)** of the **Organ of Corti**. These cells are more susceptible than inner hair cells because they accumulate the drug more readily. The damage typically begins at the **basal turn** of the cochlea. Since the basal area is responsible for processing **high-frequency sounds**, patients initially present with high-frequency hearing loss before it progresses to lower frequencies (apical area). **Why other options are incorrect:** * **Options B & D:** While Inner Hair Cells (IHCs) can eventually be affected in severe, prolonged toxicity, the **Outer Hair Cells** are always the primary and initial target. * **Options C & D:** The **apical area** of the cochlea processes low-frequency sounds. Aminoglycoside damage is characteristically **descending**, meaning it starts at the base (high frequency) and moves toward the apex (low frequency) only as toxicity worsens. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Aminoglycosides generate reactive oxygen species (ROS) in the inner ear, leading to apoptosis of hair cells. * **Specific Drugs:** **Neomycin, Amikacin, and Kanamycin** are primarily **cochleotoxic**, whereas **Streptomycin and Gentamicin** are primarily **vestibulotoxic**. * **Risk Factors:** Toxicity is increased by concurrent use of **Loop Diuretics** (e.g., Furosemide), which increases the concentration of aminoglycosides in the endolymph. * **Monitoring:** High-frequency audiometry is the most sensitive method for early detection of ototoxicity.

Q: Chloroquine is given as a 600 mg loading dose because:

It has increased tissue binding.. Explanation: The correct answer is **C. It has increased tissue binding.** Chloroquine is characterized by an exceptionally large **Volume of Distribution ($V_d$)**, often exceeding 10,000–20,000 L. This is because the drug extensively binds to tissues, particularly melanin-rich tissues (retina), liver, spleen, and lungs. When a drug has high tissue binding, it takes a significant amount of time for the plasma concentration to reach a therapeutic steady state. A **loading dose** (600 mg base) is administered to rapidly saturate these tissue binding sites and ensure that an effective concentration is achieved in the blood to act against the erythrocytic stages of *Plasmodium* [1]. **Analysis of Incorrect Options:** * **A. It is rapidly absorbed:** While Chloroquine is indeed well-absorbed from the GI tract, rapid absorption is an indication for a fast onset of action, not a reason for a high loading dose. * **B. It is rapidly metabolized:** Chloroquine is metabolized slowly by the liver (CYP enzymes). If a drug were metabolized rapidly, it would require frequent maintenance doses, not necessarily a large loading dose. * **D. It is rapidly eliminated:** Chloroquine has a very long elimination half-life ($t_{1/2}$) of about 30–60 days due to its slow release from tissue stores. Rapid elimination would necessitate a continuous infusion or frequent dosing. **Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Inhibits heme polymerase (biocrystallization), leading to the accumulation of toxic heme in the parasite. * **Drug of Choice:** Still the DOC for sensitive *P. falciparum* and *P. vivax* (erythrocytic stages). * **Adverse Effects:** Pruritus (common in Africans), bull’s eye maculopathy (retinopathy), and QTc prolongation. * **Safe in Pregnancy:** Chloroquine is considered the safest antimalarial during pregnancy.

Question 1

What is the drug of choice for gonococcal and non-gonococcal urethritis?

Accepted Answer

Azithromycin

Answer

Clindamycin

Answer

Cefepime

Answer

Metronidazole

Question 2

Which of the following is the drug of choice for invasive aspergillosis?

Accepted Answer

Voriconazole

Answer

Posaconazole

Answer

Amphotericin B

Answer

Caspofungin

Question 3

What is the drug of choice for uncomplicated cystitis?

Accepted Answer

Fosfomycin

Answer

Amoxicillin

Answer

Chloramphenicol

Answer

Cotrimoxazole

Question 4

Which antibiotic accentuates the neuromuscular blockade produced by pancuronium?

Accepted Answer

Streptomycin

Answer

Erythromycin

Answer

Penicillin G

Answer

Chloramphenicol

Question 5

Ketoconazole is useful in all of the following except?

Accepted Answer

Tinea capitis

Answer

Tinea cruris

Answer

Tinea versicolor

Answer

Tinea corporis

Question 6

Which of the following statements is true regarding Atazanavir?

Accepted Answer

Resistance is due to mutation in codon 50 isoleucine to valine substitution

Answer

Effective against only HIV-1

Answer

Decreases cholesterol and triglyceride levels

Answer

Combination with ritonavir has no advantage

Question 7

Which of the following drugs does NOT inhibit bacterial cell wall synthesis?

Accepted Answer

Spectinomycin

Answer

Vancomycin

Answer

Aztreonam

Answer

Cephalexin

Question 8

Which of the following antibiotics acts by inhibiting the 30S ribosomal subunit?

Accepted Answer

Tetracycline

Answer

Chloramphenicol

Answer

Erythromycin

Answer

Penicillin

Question 9

Aminoglycosides affect which part of the cochlea?

Accepted Answer

Outer hair cells in the basal area

Answer

Inner hair cells in the basal area

Answer

Outer hair cells in the apical area

Answer

Inner hair cells in the apical area

Question 10

Chloroquine is given as a 600 mg loading dose because:

Accepted Answer

It has increased tissue binding.

Answer

It is rapidly absorbed.

Answer

It is rapidly metabolized.

Answer

It is rapidly eliminated.

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?